Zobrazeno 1 - 10
of 88
pro vyhledávání: ''
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The enzootic and zoonotic nature of H9N2 avian influenza viruses poses a persistent threat to the global poultry industry and public health. In particular, the emerging sublineage h9.4.2.5 of H9N2 viruses has drawn great attention. In this study, we
Autor:
Robbert Boudewijns, Ji Ma, Lorena Sanchez-Felipe, Dieudonné Buh Kum, Johan Neyts, Kai Dallmeier, Niraj Mishra, Hendrik Jan Thibaut, Thomas Vercruysse
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The live-attenuated yellow fever 17D (YF17D) vaccine is one of the most efficacious human vaccines and also employed as a vector for novel vaccines. However, in the lack of appropriate immunocompetent small animal models, mechanistic insight in YF17D
Autor:
Jianhui Nie, Youchun Wang, Susu Liu, Rui Xiong, Chunnan Liang, Yong Wu, Changfa Fan, Zhe Qu, Weijin Huang, Yanwei Yang
Publikováno v:
Emerging Microbes & Infections. 10:1180-1190
Hand-foot-and-mouth disease is a contagious disease common among children under 5 years old worldwide. It is caused by strains of enterovirus, especially EV-A71, which can lead to severe disease. Vaccines are the only way to fight this disease. Accor
Autor:
Shuofeng Yuan, Hua-Rui Gong, Jian-Dong Huang, Xuansheng Lin, Ying Dou, Y.F. Hu, Kelvin K. W. To, Jasper Fuk-Woo Chan, Vincent Kwok-Man Poon, Smaranda Ruxandra Badea, Jingchu Hu, Zhiwei Chen, Hin Chu, Kaiming Tang, Chris Chun-Yiu Chan, Jian-Piao Cai, Wen-Jun Li, Li Liu, Xiao-lei Wang, Kwok-Yung Yuen, Baozhong Zhang, Xuechen Li, Ivan Hung, Kenn Ka-Heng Chik, Chris Chung-Sing Chan
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The Coronavirus Disease 2019 (COVID-19) pandemic is unlikely to abate until sufficient herd immunity is built up by either natural infection or vaccination. We previously identified ten linear immunodominant sites on the SARS-CoV-2 spike protein of w
Autor:
Zhaoming Chen, Yijun Deng, Linbing Qu, Xiaodi Fan, Song Li, Xuefeng Niu, Xiaoneng Mo, Jian Han, Yunfei Chen, Feng Li, Xinglong Liu, Ling Chen, Kun Luo, Liqiang Feng, Qihong Yan, Ruitian Hou, Qian Wang, Xiaohan Huang, Ping He, Yudi Zhang, Huan Liang, Xiaoli Xiong, Pingchao Li, Haisu Yi
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Monoclonal antibodies (mAbs) encoded by IGHV3-53 (VH3-53) targeting the spike receptor-binding domain (RBD) have been isolated from different COVID-19 patients. However, the existence and prevalence of shared VH3-53-encoded antibodies in the antibody
Autor:
Lishuang Shen, Jaclyn A. Biegel, Timothy J. Triche, Xiaowu Gai, Jennifer Dien Bard, Alexander R. Judkins
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The SARS-CoV-2 B.1.1.7 lineage is highly infectious and as of April 2021 accounted for 92% of COVID-19 cases in Europe and 59% of COVID-19 cases in the U.S. It is defined by the N501Y mutation in the receptor binding domain (RBD) of the Spike (S) pro
Autor:
Junhui Xiong, Ningshao Xia, Yangtao Wu, Tianying Zhang, Rao Fu, Sheng Nian, Zonglin Li, Shuping Tong, Shengxiang Ge, Yali Zhang, Min Wei, Tian-Shu Shi, Chen Zimin, Yingbin Wang, Quan Yuan, Jia-Qi Liu, Jun Zhang, Shaojuan Wang
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Hepatitis B e antigen (HBeAg) is a widely used marker both for chronic hepatitis B (CHB) clinical management and HBV-related basic research. However, due to its high amino acid sequence homology to hepatitis B core antigen (HBcAg), most of available
Autor:
Ya na Zhou, Yong Yang, Xi Wang, Hui Wang, Rong Hui Du, Wei Zhang, Bei Li, Zhengli Shi, Xu Rui Shen, Xian-En Zhang, Qian Li, Yan Zhu, Dong Men, Peng Zhou, Hao Rui Si, Xiao lin Tong
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Without an effective vaccine against SARS-CoV-2, the build-up of herd immunity through natural infection has been suggested as a means to control COVID-19. Although population immunity is typically estimated by the serological investigation of recove
Autor:
João Sette Whitaker Ferreira, Tamara Hakobyan, Fernando Ferreira, Hovakim Zakaryan, Harutyun Sahakyan, Elmira K. Hakobyan, Arsen Sargsyan, Zaven A. Karalyan, Anush A. Hovakimyan, Astghik Hakobyan, Grigor Arakelov, Roza Izmailyan, Marco Neves, L.O. Abroyan, Garri Chilingaryan, Erik Arabyan, Andre Serobian, Elina Arakelova, Karen Nazaryan, Samvel N. Sirakanyan
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Emerging Microbes & Infections
article-version (VoR) Version of Record
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Emerging Microbes & Infections
article-version (VoR) Version of Record
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which per
Autor:
Lin-Lei Chen, Kwok-Yung Yuen, Shannon Wing-Ngor Au, Kin-Hang Kok, Kelvin K. W. To, Joy-Yan Lam, Xiaohui Wang
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Given the on-going SARS-CoV-2 pandemic, identification of immunogenic targets against the viral protein will provide crucial advances towards the development of sensitive diagnostic tools and vaccination strategies. Our previous study has found that